awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35681671-A5019DCA-821F-410E-BE8A-B02CFD92B251
Q35681671-A5019DCA-821F-410E-BE8A-B02CFD92B251
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35681671-A5019DCA-821F-410E-BE8A-B02CFD92B251
Quantitative benefit-harm assessment for setting research priorities: the example of roflumilast for patients with COPD
P2860
Q35681671-A5019DCA-821F-410E-BE8A-B02CFD92B251
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35681671-A5019DCA-821F-410E-BE8A-B02CFD92B251
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
df7ff6f849ea5909dfda3397b47c77f827184e66
P2860
Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial.